Defense World
25 Apr 2026, 06:38 UTC · 28w ago
Verdict
Headline takes no side. We score UPC −0.60 across three claims — strongly bearish.
−0.60strongly bearish
More negative than 86% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Universe Pharmaceuticals reported quarterly revenue of $8.92 billion and earnings per share of $0.69.
So whatAn $8.92 billion revenue figure for a clinical-stage biotech is an extreme outlier that, if accurate and digested by investors, would represent a massive positive fundamental revaluation.
More positive than 98% of claims this week
The sole analyst covering Universe Pharmaceuticals rates the stock as Sell, with Weiss Ratings reiterating a sell (e+) rating.
So whatUnanimous sell ratings from analysts signal significant downside risk or overvaluation concerns to market participants.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More negative than 88% of claims this week
Universe Pharmaceuticals' stock price is trading at $3.28, well below its 200-day moving average of $3.80.
More negative than 76% of claims this week
Which stocks this story touches
More negative than 86% of ticker scores this week
The stock price fell, and the company holds an average analyst rating of 'Sell'.
More negative than 80% of ticker scores this week
The company's shares decreased by 2.3%.
More positive than 63% of ticker scores this week
The stock price crossed above the two hundred day moving average, which is typically a bullish technical signal.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
1h ago
−53.4%
Price agrees with the score
$1.53 vs $3.28 close before publication (Apr 24) · not market-adjusted
UPC chart →
